Qingsong Capital

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Oukejian specializes in researching and developing innovative large-molecule drugs for prevalent fundus diseases.

Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.

Worg Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing innovative treatments for allergies and autoimmune diseases. The company aims to address high unmet medical needs through a robust pipeline that utilizes two core technology platforms, PCFiT and Apitope, alongside collaborations with external partners. Worg also works on a platform for molecular allergy diagnosis, further enhancing its capabilities in the allergy treatment domain. By leveraging both internal development and flexible partner models, Worg Pharmaceuticals seeks to expedite the advancement of effective therapies and improve patient outcomes in the field of immunotherapy.

Weixu Biotechnology is a livestock biotechnology business that produces and markets animal serum, animal blood products, and biological raw materials. It also offers sales and technical services for animal products, feed additives, microbiological preparations, animal nutritional health products, and feed raw materials.

Meson Technology is a provider of chemical technology services specializing in the deployment of continuous-flow chemical technology systems. Its operations include continuous manufacturing methods for fine chemicals and biopharmaceutical goods, as well as continuous environmental protection treatment.

Cornerstone Robotics is a company dedicated to enhancing the accessibility of advanced medical services in China through the development of innovative medical robotic devices. Its primary focus lies in creating a safe and efficient surgical robotics platform that empowers physicians to perform surgeries with greater accuracy and efficiency. By investing in research and development, Cornerstone Robotics aims to advance the field of surgical robotics, thereby improving patient outcomes and transforming surgical practices.

Meichuang Medical is an innovative medical device company that focuses on the R&D, manufacturing and commercialization of high-end medical devices in the fields of peripheral vascular intervention, tumor intervention, and hemodialysis access maintenance

Bio-Engine is a company based in Shanghai, China, focused on the research and development of veterinary biological products. Founded in 2014, Bio-Engine specializes in creating and producing antibodies, recombinant proteins, and vaccines for both humans and livestock using serum-free suspension culture technology for animal cells. The company's expertise extends to providing clinical trial services for pharmaceutical manufacturers and scientific research units.

Ouli Biomedical is a pharmaceutical company. They offer nucleic acid drug discovery, laboratory research and development, process and analysis development, CMC services, API production, and drug registration.

Cospowers is a technology-driven company specializing in smart lithium battery solutions for a global clientele. Founded in 2003, the company focuses on the development and manufacturing of rechargeable batteries, chargers, and power battery packs. Cospowers employs advanced technology, scientific management methods, and enhanced detection techniques to ensure the safety and reliability of its products, which have received widespread acceptance among customers. In addition to its core battery offerings, the company provides comprehensive energy storage solutions, including systems for network energy, electric energy storage, and consumer applications, all aimed at promoting clean, efficient, and economical energy use.

CATUG Biotechnology specializes in the development and application of innovative biomedical technologies, particularly in the realm of gene therapy and nucleic acid drugs. The company offers comprehensive contract development and manufacturing organization (CDMO) services that span the entire industry chain, from research and development to clinical applications and industrialization. With research and development centers and industrialization bases situated in Suzhou and Wuhan, CATUG is well-equipped to support the drug research and production needs of its clients.

Ionova Life Science Co., Ltd. is a biotechnology company founded in 2016 and based in Shenzhen, China, with additional offices in Hong Kong, Macao, and the Greater Bay Area. The company specializes in the discovery and development of novel medicines for cancer treatment, focusing on oncology, including immune-oncology and targeted delivery approaches. Ionova is dedicated to creating innovative tumor-targeted drugs and immunomodulatory therapies for cancer and related diseases, employing its proprietary discovery platform to advance its research and product development initiatives.

Stemirna Therapeutics is a RNA technology based drug development company designed to maximize the potential of RNA science. The company currently has more than a dozen of independently-developed mRNA drug projects, focusing on the fields of mRNA-based personalized cancer vaccines, mRNA vaccines for infectious disease, protein defects diseases, and genetic diseases, providing cure and solutions for cancer and infectious diseases, better serving patients.

LaNova Medicines is a clinical-stage innovative drug research and development company. The company focuses on the unmet therapeutic needs in the field of tumor immunity and tumor microenvironment and focuses on the research and development of "world's first" and "best-in-class" potential bio-innovative drugs.

MEDx is a company specializing in precision medicine solutions aimed at enhancing clinical development. Founded in 2013 and headquartered in Suzhou, Jiangsu, MEDx employs translational science to advance diagnostic technologies related to nucleic acids and proteins. Its comprehensive services include biomarker development, Companion Diagnostics, Point-of-Care development, clinical testing, and the commercialization of medical products. By focusing on individualized treatment, MEDx seeks to improve patient outcomes through its innovative approaches in the healthcare sector.